Axonics Inc
Officers & Directors
1. Raymond W. Cohen - CEO and Director
Raymond W. Cohen has been with Axonics Inc since 2013 and he has extensive experience in the medical device industry. Prior to joining Axonics, he served as the CEO of Vessix Vascular, a medical device company developing renal denervation systems. Previously, he held executive positions at FoxHollow Technologies, Crescendo Medical, and Heartport.
2. Karen L. Noblett, MD - Chief Medical Officer
Karen L. Noblett, MD is a board-certified urologist who oversees Axonics' clinical development efforts. Previously, she served as a Professor of Clinical Urology and Vice-Chair of Women's Health in the Department of Urology at the University of California, Los Angeles.
3. Dan Whittle - CFO
Dan Whittle is a seasoned finance executive with over 25 years of experience. Prior to joining Axonics in 2019, he held finance leadership roles at a variety of technology companies, including Teradata Corporation and San Diego-based ecoATM.
4. Moji James - SVP Global Marketing
Moji James has more than 20 years of experience in marketing and commercialization of medical devices. Prior to joining Axonics in 2019, she held senior marketing positions at several medical device companies, including Medtronic, Boston Scientific and St. Jude Medical.
5. Michael H. Weinstein MD - Director
Michael H. Weinstein is a physician and experienced healthcare investor. He is the Vice Chairman of OpGen, a genomic analytics company, and he also serves on the board of directors of several other life sciences and technology companies.
6. Ammar Qadan - Director
Ammar Qadan is a Partner and Co-Founder of Target Global, a European venture capital firm. He has extensive experience in the technology and healthcare industries, and he has invested in companies such as DocPlanner, Medigo, and Raisin.
7. Casey Tansey - Director
Casey Tansey is a Principal at Endeavour Vision, a growth-stage venture capital firm focused on life sciences and technology. Prior to Endeavour, he worked at both Goldman Sachs and JP Morgan in their healthcare investment banking practices.
Axonics Inc currently has 325 employees.
|
